Good day, bad day: March 8, 2012
A new heart drug prevents racism, while a caffeine inhaler gets ripped by the FDA — and more winners and losers of today's news cycle

GOOD DAY FOR:
Vegetarians
A new study shows that people who eat more vegetables boast skin with a noticeably "healthy glow." [NPR]
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
In-flight outsourcing
A new company called Nanny in the Clouds matches traveling parents with experienced babysitters aboard their flight. [TIME]
Helpful side effects
Researchers say a heart disease drug may help prevent racism. They explain the connection by noting that the drug reduces anxiety, and racism is, at least in part, fueled by fear. [Telegraph]
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
BAD DAY FOR:
Truth in advertising
The FDA scolds the makers of AeroShot, supposedly a "caffeine inhaler," for false and misleading labeling. [UPI]
Abercombie and Fitch
A leaked email reveals that store employees are forced to do military-style exercises when they make mistakes. [Business Insider]
Moonlighting
A California middle school teacher is placed on leave after a student discovers that she was also working as a porn star. [Newser]
For more winners and losers see: Good day, bad day: March 7, 2012
-
Japan's prime minister feels pressure after election losses
Speed Read Shigeru Ishiba has vowed to remain in office
-
Trump orders NFL team to change name, or else
Speed Read The president wants the Washington Commanders to change its name back to the 'Redskins'
-
Are referees and 'physicality' hurting the WNBA?
Today's Big Question The league is growing, but Caitlin Clark's absence raises questions